GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | 8/17/2026 4:07:54 PM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $7,942,205 | EPS $0.06 | Export Earnings Model | ||
| ENDRA Life Sciences Inc. (NDRA) | 8/14/2026 4:24:23 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $7,942,205 | EPS $0.06 | ||
| ENDRA Life Sciences Inc. (NDRA) | 5/18/2026 8:10:36 AM | View | Financials | Earnings | WIRE | 1Q 2026 | Assets $3,438,182 | EPS -$1.09 | Export Earnings Model | ||
| ENDRA Life Sciences Inc. (NDRA) | 5/15/2026 4:13:40 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $3,438,182 | EPS -$1.09 | ||
| ENDRA Life Sciences Inc. (NDRA) | 3/31/2026 5:24:55 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $3,853,797 | EPS -$8.93 | ||
| ENDRA Life Sciences Inc. (NDRA) | 3/31/2026 4:34:49 PM | View | Financials | Earnings | SEC | Y 2025 | Assets $3,853,797 | EPS -$3.25 | Export Earnings Model | ||
| ENDRA Life Sciences Inc. (NDRA) | 11/17/2025 8:04:56 AM | View | Financials | Earnings | WIRE | 3Q 2025 | Assets $1,964,108 | EPS -$2.10 | Export Earnings Model | ||
| ENDRA Life Sciences Inc. (NDRA) | 11/14/2025 4:36:02 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $1,964,108 | EPS -$2.10 | ||
| ENDRA Life Sciences Inc. (NDRA) | 10/28/2025 7:03:12 AM | View | Proxy | SEC | Y 2024 | ||||||
| ENDRA Life Sciences Inc. (NDRA) | 8/14/2025 4:26:34 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $2,807,672 | |||
| ENDRA Life Sciences Inc. (NDRA) | 8/14/2025 4:13:32 PM | View | Financials | Earnings | WIRE | 2Q 2025 | Assets $2,807,672 | Export Earnings Model | |||
| ENDRA Life Sciences Inc. (NDRA) | 7/9/2025 4:53:49 PM | View | Financials | Earnings (Prelim) | SEC | 2Q 2025 | Export Earnings Model | ||||
| ENDRA Life Sciences Inc. (NDRA) | 5/15/2025 5:05:15 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $3,170,598 | |||
| ENDRA Life Sciences Inc. (NDRA) | 5/15/2025 4:59:38 PM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $3,170,598 | Export Earnings Model | |||
| ENDRA Life Sciences Inc. (NDRA) | 4/7/2025 6:12:02 AM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 12/31/2024 | Assets $4,452,362 | EPS -$56.94 | ||
| ENDRA Life Sciences Inc. (NDRA) | 3/31/2025 9:04:19 AM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $4,452,362 | EPS -$56.94 | ||
| ENDRA Life Sciences Inc. (NDRA) | 3/31/2025 8:51:08 AM | View | Financials | Earnings | SEC | Y 2024 | Assets $4,452,362 | Export Earnings Model | |||
| ENDRA Life Sciences Inc. (NDRA) | 11/21/2024 5:19:54 PM | Micro | View | Financials | 10-Q/A | SEC | 3Q 2024 ending: 9/30/2024 | Assets $8,379,110 | |||
| ENDRA Life Sciences Inc. (NDRA) | 11/15/2024 4:08:43 PM | View | Financials | Earnings | SEC | 3Q 2024 | Assets $8,379,110 | Export Earnings Model | |||
| ENDRA Life Sciences Inc. (NDRA) | 9/16/2024 5:29:40 PM | View | Proxy | SEC | Y 2023 | ||||||
| ENDRA Life Sciences Inc. (NDRA) | 8/23/2024 4:08:25 PM | View | Financials | Earnings | SEC | 2Q 2024 | Assets $10,442,529 | Export Earnings Model | |||
| ENDRA Life Sciences Inc. (NDRA) | 8/14/2024 4:20:15 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $10,442,529 | |||
| ENDRA Life Sciences Inc. (NDRA) | 6/25/2024 4:07:48 PM | View | Proxy | SEC | Y 2023 | ||||||
| ENDRA Life Sciences Inc. (NDRA) | 5/14/2024 4:38:25 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $5,060,701 | |||
| ENDRA Life Sciences Inc. (NDRA) | 5/14/2024 4:20:11 PM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $5,060,701 | Export Earnings Model | |||
| ENDRA Life Sciences Inc. (NDRA) | 5/10/2024 5:19:19 PM | View | Financials | Earnings (Prelim) | SEC | 1Q 2024 | Export Earnings Model | ||||
| ENDRA Life Sciences Inc. (NDRA) | 3/28/2024 4:58:57 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $6,754,146 | |||
| ENDRA Life Sciences Inc. (NDRA) | 3/28/2024 4:14:27 PM | View | Financials | Earnings | SEC | Y 2023 | Assets $6,754,146 | Export Earnings Model | |||
| ENDRA Life Sciences Inc. (NDRA) | 11/14/2023 5:35:07 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $7,602,917 | |||
| ENDRA Life Sciences Inc. (NDRA) | 11/14/2023 4:38:51 PM | View | Financials | Earnings | SEC | 3Q 2023 | Assets $7,602,917 | Export Earnings Model | |||
| ENDRA Life Sciences Inc. (NDRA) | 8/14/2023 4:56:38 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $9,244,776 | |||
| ENDRA Life Sciences Inc. (NDRA) | 8/14/2023 4:22:55 PM | View | Financials | Earnings | SEC | 2Q 2023 | Assets $9,244,776 | Export Earnings Model | |||
| ENDRA Life Sciences Inc. (NDRA) | 5/24/2023 4:11:37 PM | View | Proxy | SEC | Y 2022 | ||||||
| ENDRA Life Sciences Inc. (NDRA) | 5/15/2023 5:10:51 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $6,654,888 | |||
| ENDRA Life Sciences Inc. (NDRA) | 5/15/2023 4:14:18 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $6,654,888 | Export Earnings Model | |||
| ENDRA Life Sciences Inc. (NDRA) | 4/18/2023 9:10:26 AM | View | Financials | Earnings (Prelim) | SEC | 1Q 2023 | Export Earnings Model | ||||
| ENDRA Life Sciences Inc. (NDRA) | 3/16/2023 4:58:13 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $9,274,147 | |||
| ENDRA Life Sciences Inc. (NDRA) | 3/14/2023 4:08:30 PM | View | Financials | Earnings | SEC | Y 2022 | Assets $9,274,147 | Export Earnings Model | |||
| ENDRA Life Sciences Inc. (NDRA) | 11/14/2022 5:14:47 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $12,342,742 | |||
| ENDRA Life Sciences Inc. (NDRA) | 11/14/2022 4:35:33 PM | View | Financials | Earnings | SEC | 3Q 2022 | Assets $12,342,742 | Export Earnings Model | |||
| ENDRA Life Sciences Inc. (NDRA) | 10/17/2022 4:16:46 PM | View | Proxy | SEC | Y 2021 | ||||||
| ENDRA Life Sciences Inc. (NDRA) | 8/15/2022 5:59:46 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $15,309,417 | |||
| ENDRA Life Sciences Inc. (NDRA) | 8/15/2022 5:23:13 PM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $15,309,417 | Export Earnings Model | |||
| ENDRA Life Sciences Inc. (NDRA) | 5/12/2022 5:19:50 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $10,936,692 | EPS -$0.07 | ||
| ENDRA Life Sciences Inc. (NDRA) | 5/12/2022 4:10:23 PM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $10,936,692 | EPS -$0.07 | Export Earnings Model | ||
| ENDRA Life Sciences Inc. (NDRA) | 5/2/2022 4:04:41 PM | View | Proxy | SEC | Y 2021 | ||||||
| ENDRA Life Sciences Inc. (NDRA) | 3/30/2022 5:17:41 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $12,874,644 | |||
| ENDRA Life Sciences Inc. (NDRA) | 3/30/2022 4:12:29 PM | View | Financials | Earnings | SEC | Y 2021 | Assets $12,874,644 | Export Earnings Model | |||
| ENDRA Life Sciences Inc. (NDRA) | 11/15/2021 5:33:43 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $15,314,206 | |||
| ENDRA Life Sciences Inc. (NDRA) | 11/15/2021 4:35:53 PM | View | Financials | Earnings | SEC | 3Q 2021 | Assets $15,314,206 | Export Earnings Model | |||
| ENDRA Life Sciences Inc. (NDRA) | 11/15/2021 4:12:46 PM | View | Financials | Earnings | WIRE | 3Q 2021 | Assets $15,314,206 | Export Earnings Model | |||
| ENDRA Life Sciences Inc. (NDRA) | 8/12/2021 5:16:01 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $17,242,633 | |||
| ENDRA Life Sciences Inc. (NDRA) | 8/12/2021 4:18:35 PM | View | Financials | Earnings | SEC | 2Q 2021 | Assets $17,242,633 | Export Earnings Model | |||
| ENDRA Life Sciences Inc. (NDRA) | 5/17/2021 5:43:36 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $18,898,819 | EPS -$0.06 | ||
| ENDRA Life Sciences Inc. (NDRA) | 5/17/2021 4:09:44 PM | View | Financials | Earnings | SEC | 1Q 2021 | Assets $18,898,819 | EPS -$0.06 | Export Earnings Model | ||
| ENDRA Life Sciences Inc. (NDRA) | 4/29/2021 4:14:25 PM | View | Proxy | SEC | Y 2020 | ||||||
| ENDRA Life Sciences Inc. (NDRA) | 4/27/2021 7:02:29 AM | View | Financials | Earnings (Prelim) | SEC | 1Q 2021 | Export Earnings Model | ||||
| ENDRA Life Sciences Inc. (NDRA) | 3/25/2021 7:42:12 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Assets $8,764,976 | |||
| ENDRA Life Sciences Inc. (NDRA) | 11/16/2020 5:14:18 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Assets $5,361,185 | EPS -$0.15 | ||
| ENDRA Life Sciences Inc. (NDRA) | 11/16/2020 4:07:10 PM | View | Financials | Earnings | SEC | 3Q 2020 | Assets $5,361,185 | EPS -$0.15 | Export Earnings Model | ||
| ENDRA Life Sciences Inc. (NDRA) | 8/17/2020 4:03:56 PM | View | Financials | Earnings | SEC | 2Q 2020 | Assets $2,862,652 | EPS -$0.20 | Export Earnings Model | ||
| ENDRA Life Sciences Inc. (NDRA) | 8/14/2020 4:14:33 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 6/30/2020 | Assets $2,862,652 | EPS -$0.20 | ||
| ENDRA Life Sciences Inc. (NDRA) | 8/3/2020 4:13:07 PM | View | Proxy | SEC | Y 2019 | ||||||
| ENDRA Life Sciences Inc. (NDRA) | 5/14/2020 5:36:36 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 3/31/2020 | Assets $4,398,887 | EPS -$0.29 | ||
| ENDRA Life Sciences Inc. (NDRA) | 5/14/2020 4:06:35 PM | View | Financials | Earnings | SEC | 1Q 2020 | Assets $4,398,887 | EPS -$0.29 | Export Earnings Model | ||
| ENDRA Life Sciences Inc. (NDRA) | 4/29/2020 4:50:31 PM | View | Proxy | SEC | Y 2019 | ||||||
| ENDRA Life Sciences Inc. (NDRA) | 3/26/2020 5:33:00 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 12/31/2019 | Assets $7,176,269 | EPS -$2.34 | ||
| ENDRA Life Sciences Inc. (NDRA) | 3/26/2020 4:09:22 PM | View | Financials | Earnings | SEC | Y 2019 | Rev $0 | Assets $7,176,269 | EPS -$1.20 | Export Earnings Model | |
| ENDRA Life Sciences Inc. (NDRA) | 11/13/2019 5:21:51 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 9/30/2019 | Assets $3,615,467 | EPS -$0.46 | ||
| ENDRA Life Sciences Inc. (NDRA) | 11/13/2019 4:06:35 PM | View | Financials | Earnings | SEC | 3Q 2019 | Assets $3,615,467 | EPS -$0.46 | Export Earnings Model | ||
| ENDRA Life Sciences Inc. (NDRA) | 8/8/2019 4:58:10 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 6/30/2019 | Assets $3,190,709 | EPS -$0.31 | ||
| ENDRA Life Sciences Inc. (NDRA) | 5/14/2019 5:26:08 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 3/31/2019 | Assets $4,636,972 | EPS -$0.37 | ||
| ENDRA Life Sciences Inc. (NDRA) | 4/15/2019 4:48:35 PM | View | Proxy | SEC | Y 2018 | ||||||
| ENDRA Life Sciences Inc. (NDRA) | 3/11/2019 5:54:13 PM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 12/31/2018 | Rev: $6,174 -98.2% | Assets $7,222,791 | EPS -$2.17 | |
| ENDRA Life Sciences Inc. (NDRA) | 3/11/2019 4:07:29 PM | View | Financials | Earnings | SEC | Y 2018 | Rev $0 | Assets $7,222,791 | EPS -$0.28 | Export Earnings Model | |
| ENDRA Life Sciences Inc. (NDRA) | 11/5/2018 5:34:12 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 9/30/2018 | Assets $1,291,914 | EPS -$0.70 | ||
| ENDRA Life Sciences Inc. (NDRA) | 8/13/2018 5:07:46 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 6/30/2018 | Assets $3,045,660 | EPS -$0.47 | ||
| ENDRA Life Sciences Inc. (NDRA) | 5/29/2018 4:00:16 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 3/31/2018 | Rev: $6,174 | Assets $3,690,070 | EPS -$0.72 | |
| ENDRA Life Sciences Inc. (NDRA) | 5/10/2018 4:17:51 PM | View | Proxy | SEC | Y 2017 | ||||||
| ENDRA Life Sciences Inc. (NDRA) | 3/20/2018 5:27:10 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 12/31/2017 | Rev: $351,622 -31.8% | Assets $6,123,702 | EPS -$1.95 | |
| ENDRA Life Sciences Inc. (NDRA) | 3/20/2018 4:04:57 PM | View | Financials | Earnings | SEC | Y 2017 | Rev $6,850 -98.7% | Assets $6,123,702 | EPS -$0.65 | Export Earnings Model | |
| ENDRA Life Sciences Inc. (NDRA) | 11/15/2017 8:35:01 AM | View | Financials | Earnings | SEC | 3Q 2017 | Rev $287,000 | Assets $7,479,726 | EPS -$0.23 | Export Earnings Model | |
| ENDRA Life Sciences Inc. (NDRA) | 11/14/2017 4:45:42 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 9/30/2017 | Rev: $287,000 | Assets $7,479,726 | EPS -$0.23 | |
| ENDRA Life Sciences Inc. (NDRA) | 8/7/2017 4:33:25 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 6/30/2017 | Rev: $57,772 | Assets $7,944,565 | EPS -$0.59 | |
| ENDRA Life Sciences Inc. (NDRA) | 6/21/2017 5:02:32 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 3/31/2017 | Assets $545,126 | EPS -$1.03 |